Group One Trading

Group One Trading’s Whitehawk Therapeutics WHWK Stock Holding History

Group One Trading’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-100	Closed	-$684	–	8437
2023 Q2	$684	Hold	100	–	–	﹤0.01%	7330
2023 Q1	$724	Buy	+100	New	+$1.07K	﹤0.01%	6846

Other funds holding WHWK

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

KVP Capital Advisors San Francisco, California $134M AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Yu Fan $97M AUM 57.2% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Group One Trading's WHWK Position: Q1 2026 in Review

Group One Trading sold out of Whitehawk Therapeutics (WHWK) in Q1 2026, closing a stake of 100 shares — an estimated $313 sold.

Group One Trading first reported a position in WHWK in Q4 2023 and held it in 3 quarters. The position peaked at $3.71K in Q4 2023. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

Group One Trading reported no remaining Whitehawk Therapeutics position as of Q1 2026 after selling out during the quarter.
Group One Trading sold 100 Whitehawk Therapeutics shares in Q1 2026, an estimated $313.
Group One Trading first reported a position in Whitehawk Therapeutics in Q4 2023 and held it in 3 quarters.
Group One Trading's Whitehawk Therapeutics position peaked at $3.71K in Q4 2023.
62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.